In a volatile market, growth stocks may seem like the least attractive options. That is because growth stocks are shares of ...

The pneumococcal conjugate vaccine – codenamed PCV21/GBP410 – has started pivotal trials in the prevention of both paediatric Streptococcus pneumoniae, which remains a major public health ...

Merck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), Capvaxive, for the prevention of invasive pneumococcal disease ...

PCV13 [pneumococcal 13-valent conjugate vaccine], or cohort 3: PPSV23 followed by or preceded by PCV13, PPSV23 preceded by PCV15 [pneumococcal 15-valent conjugate vaccine], or PCV15 alone).

Childhood vaccinations have not recovered from the slump that happened after the pandemic, according to new research.

Advisory Committee on Immunization Practices voted overwhelmingly in support of expanding usage recommendations for pneumococcal conjugate vaccines (PCVs). Now, the shots are recommended for all ...

Supporting Platform’s Potential to Deliver Broadest-Spectrum Infant Pneumococcal Conjugate Vaccine (PCV) Candidates -- -- Company Selects VAX-24 Mid Dose (2.2mcg) as Basis for Optimized Dose ...

Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks and even land you in the hospital. Medical experts want you to know that there are steps you ...

Some vaccine candidates that are already in phase III development include a 21-valent pneumococcal conjugate vaccine and a next-generation rabies vaccine. Sanofi expects its annual net sales to be ...

Malini B. DeSilva, M.D., from HealthPartners Institute in Bloomington, Minnesota, and colleagues examined rotavirus; diphtheria, tetanus, and acellular pertussis; and pneumococcal conjugate vaccine ...

Babies treated with antibiotics in the first few weeks of their life are likely to show weaker immune responses to essential ...